(Date:11/20/2008)...0 The National Minority... Medical Association,s recent decision to develop ...sician and patient advocates to join the Forum in ...rance plans. , , "Physicians and lawyers --...ry A. Puckrein, PhD, President and Chief Executive...
(Date:11/20/2008)...RRISTOWN, N.J., Nov. 20 /PRNewswire/ Bayer HealthC...munity Food Bank of New Jersey,(CFBNJ) in respons...local,pharmaceutical companies to help restock su... http://www.newscom.com/cgi-bin/prnh/20081120/NET...al Communications, and Anne King,manager, Field ...
(Date:11/20/2008)...Nov. 20 An investor group in Trini...developer and manufacturer of,diagnostic products...epository,Receipts on NASDAQ, is encouraged that ...directors. , Commenting on the news, Tom Re...ed to serve as an independent director, bringing t...
(Date:11/20/2008)...outine exams, 60,000 Americans were infected last ...ws) -- Two years after U.S. health officials recom... such testing remains hit-and-miss, and the AIDS e...ting guidelines and better testing methods, accord...shington D.C. The meeting was designed to review t...
Breaking Medicine News(10 mins):Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2Health News:Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governor's Plea to Help the State's Population in Need 2Health News:Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors 2Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3...etamine, a highly addictive stimulant drug, whose ...ts of the world, causes long-term changes in the h...y and motor coordination, according to a study pub...earchers found that these effects are seen even in...
... scientists say they have developed a cheap, pain-...urs when airflow vibrates across the soft palate t...eplasty" procedure involves injecting a chemical c...t palate at the back of the throat. The snoreplast...
... of Indians are at risk of developing osteoporosis...se, men are equal sufferers from it. It is estimat...t chance of developing an osteoporotic fracture du...d to treat osteoporosis, can be grouped into two c...
...chnique for checking the spread of cancer of the o...Cancer of the oesophagus - the tube leading from t...ear in the UK, making it the eighth most common ca...rough the lymph glands. But it is hard for doctors...
Other Medicine News:Health News:Drug abuse leads to long standing changes in the brain 2Health News:Drug abuse leads to long standing changes in the brain 3Health News:Osteoporosis Drugs: right time to take-off 2(Date:11/18/2008)...e-FirstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a ...evelopment Company,and Sosei Group Corporation (...rnational biopharmaceutical company, today announc...al pre-clinical efficacy data for NSL-043/SD118.,...or neuropathic pain and has,successfully complete...
(Date:11/18/2008)...swire-USNewswire/ -- Forty-two leading U. S. scien...nal forum to consider cutting-edge innovations tha...economy from outbreaks of dangerous zoonotic disea...mong those innovations: , , , , ...that detects highly contagious and dangerous zoono...
(Date:11/13/2008)...RNewswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: HO...er of premium,diagnostics, medical imaging systems...althcare needs of women, today announced the resul...trial. The Cervista HPV high-risk,test is currentl...ted to be,launched in the European Union (EU) earl...
(Date:11/12/2008)...ire-USNewswire/ -- A new study being,published in ...wer the,question, what causes Parkinson,s disease?...al research into,Parkinson,s disease is what cause...irst place. Answering this question has been espec...ical types of brain cells that produce,dopamine an...
Breaking Medicine Technology:Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4A Window Into Parkinson's Disease 2Family History Plays Role in Black Colon Screen Rates 21295 1Family History Plays Role in Black Colon Screen Rates 21295 2Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2361 1Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2361 2Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2361 3Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2361 4Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 21289 1Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 21289 2Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 21289 3Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 1Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 2Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 3Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 4Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 5...e 15, 2007 /PRNewswire/ -- Solstice,Neurosciences,...icenter, forced dose escalation study of Botulinum...ently presented at the 11th,International Congress...rkey. , This was the first multicenter study to co...eatment doses of 10,000 Units, 12,500,Units, and 1...
... Demonstrated for an AI Over Tamoxifen in,a Single... of the entire,population of a single trial has de...n be significantly improved by switching from,tamo...e,Arimidex,-,Nolvadex 95, (ARNO 95) study, publis...nfirms that postmenopausal women,who have been tak...
Other Medicine Technology:Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 2Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 3Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5Silhouette is easy to use with uncompromised biomechanics and is the most refined posterior fixation system.
The CD Horizon Legacy Spinal System is part of the CD Horizon Spinal System designed for use in small stature patients. The posterior implants (hook and screws) are designed to fit patients in the ra
The Crossover system of implants and instruments provides rotational rigidity to a wide range of posterior rod construct in the thoracic and lumbar spine. The twelve crossconnectors in this system ar
Multiwindow transcranial and peripheral Doppler system.
Medicine Products: